The Commission argues that this reduced contribution, in comparison with the proposed 50% for costs related to an outbreak of HPAI, is justified due to the reduced risk from LPAI.
The Commission argues that this reduced contribution, in comparison with the proposed 50% for costs related to an outbreak of HPAI, is justified due to the reduced risk from LPAI.